Prestigious award for Lena Maier-Hein from the DKFZ
Press release of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
This year's Baden-Württemberg State Research Prize (Landesforschungspreis) for excellence in applied research has been awarded to Lena Maier-Hein from the German Cancer Research Center (DKFZ). The jury honored her pioneering work on the development and validation of new methods of AI-based imaging. The award, which is endowed with 100,000 euros, will be presented at a ceremony on October 22.
Informatician Lena Maier-Hein works at the interface of artificial intelligence (AI) and surgical imaging. Her research, which is strongly focused on clinical feasibility, makes a significant contribution to ensuring that oncological surgery is not only dependent on the surgeon's excellent individual expertise: The AI-based methods developed in her division allow surgical teams to gain better insights into internal body processes during an operation.
"We are thrilled that Lena Maier-Hein has received this prestigious award from the state of Baden-Württemberg and congratulate her on her success. She is an outstanding scientist whose innovative research approaches will have a significant impact on the surgery of the future. The prize is very well deserved," says Michael Baumann, Chairman of the DKFZ Board of Directors.
Lena Maier-Hein works closely with scientific, clinical and industrial partners. Her work is highly innovative and has opened new doors that also enable important next steps for other researchers. Her diverse clinical applications and industrial collaborations demonstrate the applicability and marketability of her research. In addition, her work on the clinically relevant validation of AI algorithms has set new standards in translational research on medical image processing.
Lena Maier-Hein heads the Division of Intelligent Medical Systems at the DKFZ and is Managing Director of the National Center for Tumor Diseases (NCT) in Heidelberg. She is a professor at both the Faculty of Medicine and the Faculty of Mathematics and Computer Science at Heidelberg University.
After studying informatics at the University of Karlsruhe and at Imperial College in London, Lena Maier-Hein conducted research for her doctorate in the Division of Biological and Medical Informatics at the DKFZ. She received her doctorate with distinction from the University of Karlsruhe in 2009 and her habilitation from the University of Heidelberg in 2013. From 2012, Maier-Hein headed the Junior Group Intelligent Medical Systems at the DKFZ, which was transformed into a division in 2016.
Lena Maier-Hein already received numerous awards as a student. In the course of her young scientific career, she went on to receive the Heinz Maier-Leibnitz Prize 2013 from the DFG, the Emil Salzer Prize 2016 from the DKFZ, the Berlin-Brandenburg Academy Prize 2017 and the German Cancer Prize 2024. She has already been selected twice by the European Research Council ERC for its prestigious funding and received an ERC Starting Grant in 2014 and an ERC Consolidator Grant in 2021.
Every two years since 1989, the State Research Prize (Landesforschungspreis) has honored outstanding scientific achievements in all disciplines, from biology and philology to finance. As the most highly endowed research prize in a federal state, it is awarded to one researcher from basic research and one from applied research. The state research prize is awarded by an interdisciplinary jury made up of renowned scientists.
A picture of the prizewinner is available at: www.dkfz.de/de/presse/pressemitteilungen/2024/bilder/Maier_Hein.jpg
Note on the use of image material for press releases
Use is free of charge. The German Cancer Research Center (DKFZ) permits use in connection with reporting on the topic of the press release or on the DKFZ in general. Please indicate as picture credits: "Source: Jutta Jung/DKFZ".
The image may only be passed on to third parties after prior consultation with the DKFZ Press Office (Tel. 06221 42 2854, e-mail: presse@dkfz.de). Use for commercial purposes is prohibited.
German Cancer Research Center (DKFZ)
With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.
To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:
- National Center for Tumor Diseases (NCT, 6 sites)
- German Cancer Consortium (DKTK, 8 sites)
- Hopp Children's Cancer Center (KiTZ) Heidelberg
- Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
- DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
- National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.
Contact for the press:
Dr. Sibylle Kohlstädt
German Cancer Research Center (DKFZ)
Strategic Communications and Public Relations
Im Neuenheimer Feld 280
69120 Heidelberg
P: +49 6221 42 2843
F: +49 6221 42 2968
E-mail: S.Kohlstaedt@dkfz.de
E-mail: presse@dkfz.de
www.dkfz.de